Kowa Research Institute, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1981-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.kowaus.com
Drug-Drug Interaction Study in Healthy Adult Volunteers
- First Posted Date
- 2014-10-27
- Last Posted Date
- 2014-10-27
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02275975
- Locations
- 🇺🇸
PPD, Austin, Texas, United States
Drug-Drug Interaction Study in Health Adult Volunteers
- First Posted Date
- 2014-10-24
- Last Posted Date
- 2014-10-24
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02273986
- Locations
- 🇺🇸
PPD, Austin, Texas, United States
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Phase 3
Terminated
- Conditions
- Acute Pain From Ankle Sprain or Strain
- Interventions
- Drug: PlaceboDrug: K-103-IP
- First Posted Date
- 2014-03-17
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 384
- Registration Number
- NCT02089425
A Thorough Corrected QT Interval Trial
Phase 1
Completed
- Conditions
- Dyslipidemia
- Interventions
- First Posted Date
- 2014-02-27
- Last Posted Date
- 2015-04-10
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT02073084
Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Safety and Tolerability
- Interventions
- Drug: K-312Drug: Placebo
- First Posted Date
- 2013-09-30
- Last Posted Date
- 2013-12-31
- Lead Sponsor
- Kowa Research Institute, Inc.
- Registration Number
- NCT01952548
Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin
Phase 4
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2011-08-24
- Last Posted Date
- 2012-07-13
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT01422382
Drug-Drug Interaction of Darunavir/Ritonavir on Pitavastatin
Phase 4
Completed
- Conditions
- Healthy
- Interventions
- Drug: Pitavastatin (NK-104)Drug: Darunavir/Ritonavir (Prezista)
- First Posted Date
- 2011-08-24
- Last Posted Date
- 2012-07-13
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT01422369
A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects
- First Posted Date
- 2011-02-23
- Last Posted Date
- 2014-04-29
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 252
- Registration Number
- NCT01301066
Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia
Phase 4
Completed
- Conditions
- Primary DyslipidemiaMixed Dyslipidemia
- Interventions
- First Posted Date
- 2010-12-08
- Last Posted Date
- 2012-05-08
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 328
- Registration Number
- NCT01256476
Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers
Phase 4
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2010-08-10
- Last Posted Date
- 2012-10-08
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT01178853
© Copyright 2025. All Rights Reserved by MedPath